Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.98M Sell
27,734
-2,207
-7% -$475K 0.54% 39
2026
Q1
$6.51M Sell
29,941
-25,986
-46% -$5.76M 0.59% 33
2025
Q4
$12.8M Sell
55,927
-352
-0.6% -$80.2K 0.76% 21
2025
Q3
$13M Buy
56,279
+2,573
+5% +$524K 0.69% 22
2025
Q2
$9.97M Buy
53,706
+2,915
+6% +$542K 0.64% 23
2025
Q1
$10.6M Buy
50,791
+644
+1% +$125K 0.67% 22
2024
Q4
$8.91M Sell
50,147
-4,666
-9% -$858K 0.56% 28
2024
Q3
$10.8M Buy
54,813
+26,580
+94% +$4.96M 0.69% 21
2024
Q2
$4.84M Sell
28,233
-1,840
-6% -$305K 0.56% 30
2024
Q1
$5.48M Sell
30,073
-1,046
-3% -$180K 0.57% 31
2023
Q4
$4.82M Buy
31,119
+4,268
+16% +$622K 0.55% 30
2023
Q3
$4M Buy
26,851
+1,873
+7% +$275K 0.47% 49
2023
Q2
$3.37M Sell
24,978
-1,956
-7% -$287K 0.41% 51
2023
Q1
$4.29M Sell
26,934
-2,008
-7% -$307K 0.56% 39
2022
Q4
$4.68M Buy
28,942
+800
+3% +$123K 0.6% 41
2022
Q3
$3.78M Sell
28,142
-7,503
-21% -$1.08M 0.51% 44
2022
Q2
$5.46M Sell
35,645
-3,287
-8% -$502K 0.72% 28
2022
Q1
$6.31M Sell
38,932
-8,474
-18% -$1.23M 0.71% 30
2021
Q4
$6.42M Buy
47,406
+554
+1% +$65.4K 0.67% 32
2021
Q3
$5.05M Buy
46,852
+12,127
+35% +$1.39M 0.55% 44
2021
Q2
$3.91M Buy
34,725
+720
+2% +$81.1K 0.44% 48
2021
Q1
$3.68M Sell
34,005
-7,401
-18% -$792K 0.47% 41
2020
Q4
$4.44M Buy
41,406
+6,581
+19% +$632K 0.62% 31
2020
Q3
$3.05M Buy
34,825
+1,637
+5% +$154K 0.52% 37
2020
Q2
$3.26M Buy
33,188
+2,818
+9% +$248K 0.6% 32
2020
Q1
$2.31M Buy
30,370
+854
+3% +$72.7K 0.56% 36
2019
Q4
$2.61M Buy
29,516
+1,171
+4% +$97.2K 0.49% 52
2019
Q3
$2.15M Buy
28,345
+203
+0.7% +$13.9K 0.41% 62
2019
Q2
$2.05M Buy
28,142
+1,171
+4% +$92K 0.43% 60
2019
Q1
$2.17M Buy
26,971
+633
+2% +$51.8K 0.46% 54
2018
Q4
$2.43M Sell
26,338
-4,361
-14% -$384K 0.6% 39
2018
Q3
$2.9M Sell
30,699
-4,983
-14% -$473K 0.61% 36
2018
Q2
$3.31M Buy
35,682
+1,210
+4% +$118K 0.7% 30
2018
Q1
$3.26M Buy
34,472
+4,040
+13% +$444K 0.57% 40
2017
Q4
$2.94M Sell
30,432
-5,925
-16% -$558K 0.66% 29
2017
Q3
$3.23M Buy
36,357
+3,491
+11% +$266K 0.98% 23
2017
Q2
$2.38M Buy
32,866
+1,293
+4% +$86.9K 0.7% 34
2017
Q1
$2.06M Sell
31,573
-181
-0.6% -$11.4K 0.62% 42
2016
Q4
$1.99M Buy
31,754
+2,315
+8% +$141K 0.62% 40
2016
Q3
$1.86M Buy
29,439
+8,208
+39% +$531K 0.58% 47
2016
Q2
$1.31M Buy
21,231
+2,728
+15% +$166K 0.42% 77
2016
Q1
$1.06M Buy
18,503
+12,318
+199% +$687K 0.33% 97
2015
Q4
$367K Buy
6,185
+356
+6% +$20.5K 0.11% 231
2015
Q3
$317K Sell
5,829
-4,635
-44% -$302K 0.09% 245
2015
Q2
$703K Buy
10,464
+1,011
+11% +$66K 0.19% 148
2015
Q1
$554K Sell
9,453
-1,961
-17% -$118K 0.14% 189
2014
Q4
$747K Sell
11,414
-1,567
-12% -$98.8K 0.26% 91
2014
Q3
$750K Sell
12,981
-1,671
-11% -$92.8K 0.34% 88
2014
Q2
$827K Buy
14,652
+6,553
+81% +$344K 0.39% 79
2014
Q1
$416K Sell
8,099
-1,235
-13% -$62.4K 0.21% 121
2013
Q4
$493K Buy
9,334
+3,812
+69% +$187K 0.25% 103
2013
Q3
$247K Buy
+5,522
New +$245K 0.14% 169

Other funds holding ABBV

Hilltop Holdings's ABBV Position: Q2 2026 in Review

Hilltop Holdings reduced its AbbVie (ABBV) stake by 7.4% in Q2 2026, selling an estimated $475K and leaving 27,734 shares worth $6.98M. The position accounts for 0.54% of the portfolio, ranked #39.

Hilltop Holdings first reported a position in ABBV in Q3 2013 and has held it in 52 quarters since. The position peaked at $13M in Q3 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Hilltop Holdings held 27,734 shares of AbbVie worth $6.98M as of Q2 2026.
  • Hilltop Holdings sold 2,207 AbbVie shares in Q2 2026, an estimated $475K.
  • AbbVie made up 0.54% of Hilltop Holdings's portfolio in Q2 2026, its #39 holding.
  • Hilltop Holdings first reported a position in AbbVie in Q3 2013 and has held it in 52 quarters since.
  • Hilltop Holdings's AbbVie position peaked at $13M in Q3 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hilltop Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.